APO Research
Talk to an analyst

APO RESEARCH · REPORT

Kangerxin Capsules

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Kangerxin Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025197 pages

Choose your research edition.

Industry ResearchKangerxin Capsules Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Kangerxin Capsules Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Kangerxin Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Kangerxin Capsules Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Kangerxin Capsules Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Kangerxin Capsules market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Kangerxin Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Kangerxin Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Kangerxin Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Kangerxin Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Kangerxin Capsules include Changsha Dongfeng Pharmaceutical Co., Ltd., Xinjiang Quan'an Pharmaceutical Co., Ltd., Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd., Weihai Norda Pharmaceutical Group Co., Ltd., Taiji Group Chongqing Traditional Chinese Medicine Factory No. 2 Co., Ltd., Suzhou Huabao Pharmaceutical Co., Ltd., Shandong Buchang Shenzhou Pharmaceutical Co., Ltd., Panjin Hengchanglong Pharmaceutical Co., Ltd. and Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Kangerxin Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Kangerxin Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Kangerxin Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Kangerxin Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.

Kangerxin Capsules Segment by Company

Changsha Dongfeng Pharmaceutical Co., Ltd.

Xinjiang Quan'an Pharmaceutical Co., Ltd.

Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd.

Weihai Norda Pharmaceutical Group Co., Ltd.

Taiji Group Chongqing Traditional Chinese Medicine Factory No. 2 Co., Ltd.

Suzhou Huabao Pharmaceutical Co., Ltd.

Shandong Buchang Shenzhou Pharmaceutical Co., Ltd.

Panjin Hengchanglong Pharmaceutical Co., Ltd.

Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd.

Liaoning Keji Pharmaceutical Co., Ltd.

Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd.

Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd.

Jilin Zhongyan Pharmaceutical Co., Ltd.

Jilin Hengjin Pharmaceutical Co., Ltd.

China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.

Henan Xinsifang Pharmaceutical Co., Ltd.

Harbin Meijun Pharmaceutical Co., Ltd.

Guizhou Yuancheng Pharmaceutical Co., Ltd.

Guangzhou Xiaoqiling Pharmaceutical Co., Ltd.

Guangzhou Baiyunshan Chenliji Pharmaceutical Factory Co., Ltd.

Guangdong Shaxi Pharmaceutical Co., Ltd.

Beijing Baoshutang Technology Pharmaceutical Co., Ltd.

Kangerxin Capsules Segment by Type

0.4g×12 Capsules×2 Plates

0.4g×12 Capsules×4 Plates

Kangerxin Capsules Segment by Application

Hospital

Clinic

Other

Kangerxin Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Kangerxin Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Kangerxin Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Kangerxin Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Kangerxin Capsules market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Kangerxin Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Kangerxin Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Kangerxin Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Kangerxin Capsules Industry Trends Table 2. Kangerxin Capsules Industry Drivers Table 3. Kangerxin Capsules Industry Opportunities and Challenges Table 4. Kangerxin Capsules Industry Restraints Table 5. Global Kangerxin Capsules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Kangerxin Capsules Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Kangerxin Capsules Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Kangerxin Capsules Sales Market Share by Manufacturers Table 9. Global Kangerxin Capsules Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Kangerxin Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Kangerxin Capsules Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Kangerxin Capsules Manufacturers, Product Type & Application Table 13. Global Kangerxin Capsules Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Kangerxin Capsules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 0.4g×12 Capsules×2 Plates Table 17. Major Manufacturers of 0.4g×12 Capsules×4 Plates Table 18. Global Kangerxin Capsules Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Kangerxin Capsules Sales by Type (2021-2026) & (K Units) Table 20. Global Kangerxin Capsules Sales by Type (2027-2032) & (K Units) Table 21. Global Kangerxin Capsules Sales Market Share by Type (2021-2026) Table 22. Global Kangerxin Capsules Sales Market Share by Type (2027-2032) Table 23. Global Kangerxin Capsules Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Kangerxin Capsules Revenue by Type (2021-2026) & (K Units) Table 25. Global Kangerxin Capsules Revenue by Type (2027-2032) & (K Units) Table 26. Global Kangerxin Capsules Revenue Market Share by Type (2021-2026) Table 27. Global Kangerxin Capsules Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Other Table 31. Global Kangerxin Capsules Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Kangerxin Capsules Sales by Application (2021-2026) & (K Units) Table 33. Global Kangerxin Capsules Sales by Application (2027-2032) & (K Units) Table 34. Global Kangerxin Capsules Sales Market Share by Application (2021-2026) Table 35. Global Kangerxin Capsules Sales Market Share by Application (2027-2032) Table 36. Global Kangerxin Capsules Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Kangerxin Capsules Revenue by Application (2021-2026) & (K Units) Table 38. Global Kangerxin Capsules Revenue by Application (2027-2032) & (K Units) Table 39. Global Kangerxin Capsules Revenue Market Share by Application (2021-2026) Table 40. Global Kangerxin Capsules Revenue Market Share by Application (2027-2032) Table 41. Global Kangerxin Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Kangerxin Capsules Sales by Region (2021-2026) & (K Units) Table 43. Global Kangerxin Capsules Sales Market Share by Region (2021-2026) Table 44. Global Kangerxin Capsules Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Kangerxin Capsules Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Kangerxin Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Kangerxin Capsules Sales by Country (2021-2026) & (K Units) Table 48. North America Kangerxin Capsules Sales by Country (2027-2032) & (K Units) Table 49. Europe Kangerxin Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Kangerxin Capsules Sales by Country (2021-2026) & (K Units) Table 51. Europe Kangerxin Capsules Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Kangerxin Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Kangerxin Capsules Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Kangerxin Capsules Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Kangerxin Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Kangerxin Capsules Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Kangerxin Capsules Sales by Country (2027-2032) & (K Units) Table 58. Global Kangerxin Capsules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Kangerxin Capsules Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Kangerxin Capsules Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Kangerxin Capsules Revenue Market Share by Region (2021-2026) Table 62. Global Kangerxin Capsules Revenue Market Share by Region (2027-2032) Table 63. Changsha Dongfeng Pharmaceutical Co., Ltd. Company Information Table 64. Changsha Dongfeng Pharmaceutical Co., Ltd. Business Overview Table 65. Changsha Dongfeng Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Changsha Dongfeng Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 67. Changsha Dongfeng Pharmaceutical Co., Ltd. Recent Development Table 68. Xinjiang Quan'an Pharmaceutical Co., Ltd. Company Information Table 69. Xinjiang Quan'an Pharmaceutical Co., Ltd. Business Overview Table 70. Xinjiang Quan'an Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Xinjiang Quan'an Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 72. Xinjiang Quan'an Pharmaceutical Co., Ltd. Recent Development Table 73. Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Company Information Table 74. Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Business Overview Table 75. Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 77. Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Recent Development Table 78. Weihai Norda Pharmaceutical Group Co., Ltd. Company Information Table 79. Weihai Norda Pharmaceutical Group Co., Ltd. Business Overview Table 80. Weihai Norda Pharmaceutical Group Co., Ltd. Kangerxin Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Weihai Norda Pharmaceutical Group Co., Ltd. Kangerxin Capsules Product Portfolio Table 82. Weihai Norda Pharmaceutical Group Co., Ltd. Recent Development Table 83. Taiji Group Chongqing Traditional Chinese Medicine Factory No. 2 Co., Ltd. Company Information Table 84. Taiji Group Chongqing Traditional Chinese Medicine Factory No. 2 Co., Ltd. Business Overview Table 85. Taiji Group Chongqing Traditional Chinese Medicine Factory No. 2 Co., Ltd. Kangerxin Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Taiji Group Chongqing Traditional Chinese Medicine Factory No. 2 Co., Ltd. Kangerxin Capsules Product Portfolio Table 87. Taiji Group Chongqing Traditional Chinese Medicine Factory No. 2 Co., Ltd. Recent Development Table 88. Suzhou Huabao Pharmaceutical Co., Ltd. Company Information Table 89. Suzhou Huabao Pharmaceutical Co., Ltd. Business Overview Table 90. Suzhou Huabao Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Suzhou Huabao Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 92. Suzhou Huabao Pharmaceutical Co., Ltd. Recent Development Table 93. Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Company Information Table 94. Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Business Overview Table 95. Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 97. Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Recent Development Table 98. Panjin Hengchanglong Pharmaceutical Co., Ltd. Company Information Table 99. Panjin Hengchanglong Pharmaceutical Co., Ltd. Business Overview Table 100. Panjin Hengchanglong Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Panjin Hengchanglong Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 102. Panjin Hengchanglong Pharmaceutical Co., Ltd. Recent Development Table 103. Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Company Information Table 104. Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Business Overview Table 105. Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 107. Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Recent Development Table 108. Liaoning Keji Pharmaceutical Co., Ltd. Company Information Table 109. Liaoning Keji Pharmaceutical Co., Ltd. Business Overview Table 110. Liaoning Keji Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Liaoning Keji Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 112. Liaoning Keji Pharmaceutical Co., Ltd. Recent Development Table 113. Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd. Company Information Table 114. Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd. Business Overview Table 115. Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 117. Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd. Recent Development Table 118. Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Company Information Table 119. Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Business Overview Table 120. Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 122. Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Recent Development Table 123. Jilin Zhongyan Pharmaceutical Co., Ltd. Company Information Table 124. Jilin Zhongyan Pharmaceutical Co., Ltd. Business Overview Table 125. Jilin Zhongyan Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Jilin Zhongyan Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 127. Jilin Zhongyan Pharmaceutical Co., Ltd. Recent Development Table 128. Jilin Hengjin Pharmaceutical Co., Ltd. Company Information Table 129. Jilin Hengjin Pharmaceutical Co., Ltd. Business Overview Table 130. Jilin Hengjin Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Jilin Hengjin Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 132. Jilin Hengjin Pharmaceutical Co., Ltd. Recent Development Table 133. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Company Information Table 134. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Business Overview Table 135. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 137. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Recent Development Table 138. Henan Xinsifang Pharmaceutical Co., Ltd. Company Information Table 139. Henan Xinsifang Pharmaceutical Co., Ltd. Business Overview Table 140. Henan Xinsifang Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Henan Xinsifang Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 142. Henan Xinsifang Pharmaceutical Co., Ltd. Recent Development Table 143. Harbin Meijun Pharmaceutical Co., Ltd. Company Information Table 144. Harbin Meijun Pharmaceutical Co., Ltd. Business Overview Table 145. Harbin Meijun Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Harbin Meijun Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 147. Harbin Meijun Pharmaceutical Co., Ltd. Recent Development Table 148. Guizhou Yuancheng Pharmaceutical Co., Ltd. Company Information Table 149. Guizhou Yuancheng Pharmaceutical Co., Ltd. Business Overview Table 150. Guizhou Yuancheng Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Guizhou Yuancheng Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 152. Guizhou Yuancheng Pharmaceutical Co., Ltd. Recent Development Table 153. Guangzhou Xiaoqiling Pharmaceutical Co., Ltd. Company Information Table 154. Guangzhou Xiaoqiling Pharmaceutical Co., Ltd. Business Overview Table 155. Guangzhou Xiaoqiling Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. Guangzhou Xiaoqiling Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 157. Guangzhou Xiaoqiling Pharmaceutical Co., Ltd. Recent Development Table 158. Guangzhou Baiyunshan Chenliji Pharmaceutical Factory Co., Ltd. Company Information Table 159. Guangzhou Baiyunshan Chenliji Pharmaceutical Factory Co., Ltd. Business Overview Table 160. Guangzhou Baiyunshan Chenliji Pharmaceutical Factory Co., Ltd. Kangerxin Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. Guangzhou Baiyunshan Chenliji Pharmaceutical Factory Co., Ltd. Kangerxin Capsules Product Portfolio Table 162. Guangzhou Baiyunshan Chenliji Pharmaceutical Factory Co., Ltd. Recent Development Table 163. Guangdong Shaxi Pharmaceutical Co., Ltd. Company Information Table 164. Guangdong Shaxi Pharmaceutical Co., Ltd. Business Overview Table 165. Guangdong Shaxi Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 166. Guangdong Shaxi Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 167. Guangdong Shaxi Pharmaceutical Co., Ltd. Recent Development Table 168. Beijing Baoshutang Technology Pharmaceutical Co., Ltd. Company Information Table 169. Beijing Baoshutang Technology Pharmaceutical Co., Ltd. Business Overview Table 170. Beijing Baoshutang Technology Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 171. Beijing Baoshutang Technology Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 172. Beijing Baoshutang Technology Pharmaceutical Co., Ltd. Recent Development Table 173. Key Raw Materials Table 174. Raw Materials Key Suppliers Table 175. Kangerxin Capsules Distributors List Table 176. Kangerxin Capsules Customers List Table 177. Research Programs/Design for This Report Table 178. Authors List of This Report Table 179. Secondary Sources Table 180. Primary Sources List of Figures Figure 1. Kangerxin Capsules Product Image Figure 2. Global Kangerxin Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Kangerxin Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Kangerxin Capsules Sales (2021-2032) & (K Units) Figure 5. Global Kangerxin Capsules Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Kangerxin Capsules Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 0.4g×12 Capsules×2 Plates Image Figure 9. 0.4g×12 Capsules×4 Plates Image Figure 10. Global Kangerxin Capsules Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Kangerxin Capsules Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Kangerxin Capsules Sales Market Share by Type (2021-2032) Figure 13. Global Kangerxin Capsules Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Kangerxin Capsules Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Kangerxin Capsules Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Other Image Figure 19. Global Kangerxin Capsules Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Kangerxin Capsules Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Kangerxin Capsules Sales Market Share by Application (2021-2032) Figure 22. Global Kangerxin Capsules Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Kangerxin Capsules Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Kangerxin Capsules Revenue Market Share by Application (2021-2032) Figure 25. North America Kangerxin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Kangerxin Capsules Sales Market Share by Country (2021-2032) Figure 27. U.S. Kangerxin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Kangerxin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Kangerxin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Kangerxin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Kangerxin Capsules Sales Market Share by Country (2021-2032) Figure 32. Germany Kangerxin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Kangerxin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Kangerxin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Kangerxin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Kangerxin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Kangerxin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Kangerxin Capsules Sales Market Share by Country (2021-2032) Figure 39. China Kangerxin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Kangerxin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Kangerxin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Kangerxin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Kangerxin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Kangerxin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Kangerxin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Kangerxin Capsules Sales Market Share by Country (2021-2032) Figure 47. Brazil Kangerxin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Kangerxin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Kangerxin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Kangerxin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Kangerxin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Kangerxin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Kangerxin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Kangerxin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Kangerxin Capsules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Kangerxin Capsules Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Kangerxin Capsules Revenue (2021-2032) & (US$ Million) Figure 58. North America Kangerxin Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Kangerxin Capsules Revenue (2021-2032) & (US$ Million) Figure 60. Europe Kangerxin Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Kangerxin Capsules Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Kangerxin Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Kangerxin Capsules Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Kangerxin Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Kangerxin Capsules Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Kangerxin Capsules Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 0.4g×12 Capsules×2 Plates
  • 0.4g×12 Capsules×4 Plates
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Changsha Dongfeng Pharmaceutical Co., Ltd.
  • Xinjiang Quan'an Pharmaceutical Co., Ltd.
  • Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd.
  • Weihai Norda Pharmaceutical Group Co., Ltd.
  • Taiji Group Chongqing Traditional Chinese Medicine Factory No. 2 Co., Ltd.
  • Suzhou Huabao Pharmaceutical Co., Ltd.
  • Shandong Buchang Shenzhou Pharmaceutical Co., Ltd.
  • Panjin Hengchanglong Pharmaceutical Co., Ltd.
  • Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd.
  • Liaoning Keji Pharmaceutical Co., Ltd.
  • Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd.
  • Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd.
  • Jilin Zhongyan Pharmaceutical Co., Ltd.
  • Jilin Hengjin Pharmaceutical Co., Ltd.
  • China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.
  • Henan Xinsifang Pharmaceutical Co., Ltd.
  • Harbin Meijun Pharmaceutical Co., Ltd.
  • Guizhou Yuancheng Pharmaceutical Co., Ltd.
  • Guangzhou Xiaoqiling Pharmaceutical Co., Ltd.
  • Guangzhou Baiyunshan Chenliji Pharmaceutical Factory Co., Ltd.
  • Guangdong Shaxi Pharmaceutical Co., Ltd.
  • Beijing Baoshutang Technology Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Kangerxin Capsules Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Kangerxin Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Kangerxin Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Kangerxin Capsules Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Kangerxin Capsules Market Dynamics
  1. 2.1 Kangerxin Capsules Industry Trends
  2. 2.2 Kangerxin Capsules Industry Drivers
  3. 2.3 Kangerxin Capsules Industry Opportunities and Challenges
  4. 2.4 Kangerxin Capsules Industry Restraints
3 Kangerxin Capsules Market by Manufacturers
  1. 3.1 Global Kangerxin Capsules Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Kangerxin Capsules Sales by Manufacturers (2021-2026)
  3. 3.3 Global Kangerxin Capsules Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Kangerxin Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Kangerxin Capsules Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Kangerxin Capsules Manufacturers, Product Type & Application
  7. 3.7 Global Kangerxin Capsules Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Kangerxin Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Kangerxin Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Kangerxin Capsules Tier 1, Tier 2, and Tier 3
4 Kangerxin Capsules Market by Type
  1. 4.1 Kangerxin Capsules Type Introduction
  2. 4.1.1 0.4g×12 Capsules×2 Plates
  3. 4.1.2 0.4g×12 Capsules×4 Plates
  4. 4.2 Global Kangerxin Capsules Sales by Type
  5. 4.2.1 Global Kangerxin Capsules Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Kangerxin Capsules Sales by Type (2021-2032)
  7. 4.2.3 Global Kangerxin Capsules Sales Market Share by Type (2021-2032)
  8. 4.3 Global Kangerxin Capsules Revenue by Type
  9. 4.3.1 Global Kangerxin Capsules Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Kangerxin Capsules Revenue by Type (2021-2032)
  11. 4.3.3 Global Kangerxin Capsules Revenue Market Share by Type (2021-2032)
5 Kangerxin Capsules Market by Application
  1. 5.1 Kangerxin Capsules Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Kangerxin Capsules Sales by Application
  6. 5.2.1 Global Kangerxin Capsules Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Kangerxin Capsules Sales by Application (2021-2032)
  8. 5.2.3 Global Kangerxin Capsules Sales Market Share by Application (2021-2032)
  9. 5.3 Global Kangerxin Capsules Revenue by Application
  10. 5.3.1 Global Kangerxin Capsules Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Kangerxin Capsules Revenue by Application (2021-2032)
  12. 5.3.3 Global Kangerxin Capsules Revenue Market Share by Application (2021-2032)
6 Global Kangerxin Capsules Sales by Region
  1. 6.1 Global Kangerxin Capsules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Kangerxin Capsules Sales by Region (2021-2032)
  3. 6.2.1 Global Kangerxin Capsules Sales by Region (2021-2026)
  4. 6.2.2 Global Kangerxin Capsules Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Kangerxin Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Kangerxin Capsules Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Kangerxin Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Kangerxin Capsules Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Kangerxin Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Kangerxin Capsules Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Kangerxin Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Kangerxin Capsules Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Kangerxin Capsules Revenue by Region
  1. 7.1 Global Kangerxin Capsules Revenue by Region
  2. 7.1.1 Global Kangerxin Capsules Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Kangerxin Capsules Revenue by Region (2021-2026)
  4. 7.1.3 Global Kangerxin Capsules Revenue by Region (2027-2032)
  5. 7.1.4 Global Kangerxin Capsules Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Kangerxin Capsules Revenue (2021-2032)
  8. 7.2.2 North America Kangerxin Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Kangerxin Capsules Revenue (2021-2032)
  11. 7.3.2 Europe Kangerxin Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Kangerxin Capsules Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Kangerxin Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Kangerxin Capsules Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Kangerxin Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Changsha Dongfeng Pharmaceutical Co., Ltd.
  2. 8.1.1 Changsha Dongfeng Pharmaceutical Co., Ltd. Company Information
  3. 8.1.2 Changsha Dongfeng Pharmaceutical Co., Ltd. Business Overview
  4. 8.1.3 Changsha Dongfeng Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Changsha Dongfeng Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  6. 8.1.5 Changsha Dongfeng Pharmaceutical Co., Ltd. Recent Developments
  7. 8.2 Xinjiang Quan'an Pharmaceutical Co., Ltd.
  8. 8.2.1 Xinjiang Quan'an Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Xinjiang Quan'an Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Xinjiang Quan'an Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Xinjiang Quan'an Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  12. 8.2.5 Xinjiang Quan'an Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd.
  14. 8.3.1 Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  18. 8.3.5 Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Weihai Norda Pharmaceutical Group Co., Ltd.
  20. 8.4.1 Weihai Norda Pharmaceutical Group Co., Ltd. Company Information
  21. 8.4.2 Weihai Norda Pharmaceutical Group Co., Ltd. Business Overview
  22. 8.4.3 Weihai Norda Pharmaceutical Group Co., Ltd. Kangerxin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Weihai Norda Pharmaceutical Group Co., Ltd. Kangerxin Capsules Product Portfolio
  24. 8.4.5 Weihai Norda Pharmaceutical Group Co., Ltd. Recent Developments
  25. 8.5 Taiji Group Chongqing Traditional Chinese Medicine Factory No. 2 Co., Ltd.
  26. 8.5.1 Taiji Group Chongqing Traditional Chinese Medicine Factory No. 2 Co., Ltd. Company Information
  27. 8.5.2 Taiji Group Chongqing Traditional Chinese Medicine Factory No. 2 Co., Ltd. Business Overview
  28. 8.5.3 Taiji Group Chongqing Traditional Chinese Medicine Factory No. 2 Co., Ltd. Kangerxin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Taiji Group Chongqing Traditional Chinese Medicine Factory No. 2 Co., Ltd. Kangerxin Capsules Product Portfolio
  30. 8.5.5 Taiji Group Chongqing Traditional Chinese Medicine Factory No. 2 Co., Ltd. Recent Developments
  31. 8.6 Suzhou Huabao Pharmaceutical Co., Ltd.
  32. 8.6.1 Suzhou Huabao Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Suzhou Huabao Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Suzhou Huabao Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Suzhou Huabao Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  36. 8.6.5 Suzhou Huabao Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Shandong Buchang Shenzhou Pharmaceutical Co., Ltd.
  38. 8.7.1 Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  42. 8.7.5 Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Panjin Hengchanglong Pharmaceutical Co., Ltd.
  44. 8.8.1 Panjin Hengchanglong Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Panjin Hengchanglong Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Panjin Hengchanglong Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Panjin Hengchanglong Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  48. 8.8.5 Panjin Hengchanglong Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd.
  50. 8.9.1 Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  54. 8.9.5 Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Recent Developments
  55. 8.10 Liaoning Keji Pharmaceutical Co., Ltd.
  56. 8.10.1 Liaoning Keji Pharmaceutical Co., Ltd. Company Information
  57. 8.10.2 Liaoning Keji Pharmaceutical Co., Ltd. Business Overview
  58. 8.10.3 Liaoning Keji Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Liaoning Keji Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  60. 8.10.5 Liaoning Keji Pharmaceutical Co., Ltd. Recent Developments
  61. 8.11 Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd.
  62. 8.11.1 Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  66. 8.11.5 Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd.
  68. 8.12.1 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Company Information
  69. 8.12.2 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Business Overview
  70. 8.12.3 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  72. 8.12.5 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Recent Developments
  73. 8.13 Jilin Zhongyan Pharmaceutical Co., Ltd.
  74. 8.13.1 Jilin Zhongyan Pharmaceutical Co., Ltd. Company Information
  75. 8.13.2 Jilin Zhongyan Pharmaceutical Co., Ltd. Business Overview
  76. 8.13.3 Jilin Zhongyan Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Jilin Zhongyan Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  78. 8.13.5 Jilin Zhongyan Pharmaceutical Co., Ltd. Recent Developments
  79. 8.14 Jilin Hengjin Pharmaceutical Co., Ltd.
  80. 8.14.1 Jilin Hengjin Pharmaceutical Co., Ltd. Company Information
  81. 8.14.2 Jilin Hengjin Pharmaceutical Co., Ltd. Business Overview
  82. 8.14.3 Jilin Hengjin Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Jilin Hengjin Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  84. 8.14.5 Jilin Hengjin Pharmaceutical Co., Ltd. Recent Developments
  85. 8.15 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.
  86. 8.15.1 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Company Information
  87. 8.15.2 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Business Overview
  88. 8.15.3 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  90. 8.15.5 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Recent Developments
  91. 8.16 Henan Xinsifang Pharmaceutical Co., Ltd.
  92. 8.16.1 Henan Xinsifang Pharmaceutical Co., Ltd. Company Information
  93. 8.16.2 Henan Xinsifang Pharmaceutical Co., Ltd. Business Overview
  94. 8.16.3 Henan Xinsifang Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Henan Xinsifang Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  96. 8.16.5 Henan Xinsifang Pharmaceutical Co., Ltd. Recent Developments
  97. 8.17 Harbin Meijun Pharmaceutical Co., Ltd.
  98. 8.17.1 Harbin Meijun Pharmaceutical Co., Ltd. Company Information
  99. 8.17.2 Harbin Meijun Pharmaceutical Co., Ltd. Business Overview
  100. 8.17.3 Harbin Meijun Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Harbin Meijun Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  102. 8.17.5 Harbin Meijun Pharmaceutical Co., Ltd. Recent Developments
  103. 8.18 Guizhou Yuancheng Pharmaceutical Co., Ltd.
  104. 8.18.1 Guizhou Yuancheng Pharmaceutical Co., Ltd. Company Information
  105. 8.18.2 Guizhou Yuancheng Pharmaceutical Co., Ltd. Business Overview
  106. 8.18.3 Guizhou Yuancheng Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Guizhou Yuancheng Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  108. 8.18.5 Guizhou Yuancheng Pharmaceutical Co., Ltd. Recent Developments
  109. 8.19 Guangzhou Xiaoqiling Pharmaceutical Co., Ltd.
  110. 8.19.1 Guangzhou Xiaoqiling Pharmaceutical Co., Ltd. Company Information
  111. 8.19.2 Guangzhou Xiaoqiling Pharmaceutical Co., Ltd. Business Overview
  112. 8.19.3 Guangzhou Xiaoqiling Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Guangzhou Xiaoqiling Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  114. 8.19.5 Guangzhou Xiaoqiling Pharmaceutical Co., Ltd. Recent Developments
  115. 8.20 Guangzhou Baiyunshan Chenliji Pharmaceutical Factory Co., Ltd.
  116. 8.20.1 Guangzhou Baiyunshan Chenliji Pharmaceutical Factory Co., Ltd. Company Information
  117. 8.20.2 Guangzhou Baiyunshan Chenliji Pharmaceutical Factory Co., Ltd. Business Overview
  118. 8.20.3 Guangzhou Baiyunshan Chenliji Pharmaceutical Factory Co., Ltd. Kangerxin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Guangzhou Baiyunshan Chenliji Pharmaceutical Factory Co., Ltd. Kangerxin Capsules Product Portfolio
  120. 8.20.5 Guangzhou Baiyunshan Chenliji Pharmaceutical Factory Co., Ltd. Recent Developments
  121. 8.21 Guangdong Shaxi Pharmaceutical Co., Ltd.
  122. 8.21.1 Guangdong Shaxi Pharmaceutical Co., Ltd. Company Information
  123. 8.21.2 Guangdong Shaxi Pharmaceutical Co., Ltd. Business Overview
  124. 8.21.3 Guangdong Shaxi Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Guangdong Shaxi Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  126. 8.21.5 Guangdong Shaxi Pharmaceutical Co., Ltd. Recent Developments
  127. 8.22 Beijing Baoshutang Technology Pharmaceutical Co., Ltd.
  128. 8.22.1 Beijing Baoshutang Technology Pharmaceutical Co., Ltd. Company Information
  129. 8.22.2 Beijing Baoshutang Technology Pharmaceutical Co., Ltd. Business Overview
  130. 8.22.3 Beijing Baoshutang Technology Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Beijing Baoshutang Technology Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  132. 8.22.5 Beijing Baoshutang Technology Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Kangerxin Capsules Value Chain Analysis
  2. 9.1.1 Kangerxin Capsules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Kangerxin Capsules Production Mode & Process
  6. 9.2 Kangerxin Capsules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Kangerxin Capsules Distributors
  9. 9.2.3 Kangerxin Capsules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst